AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Dec 27 2021
News
Experts Warn Pfizer Antiviral Pills May Pose Risks With Other Medications
Experts warn that despite the first antiviral pills for COVID-19 promising protection for those at risk of severe disease, Pfizer's or Merck's new medications may not be safe for everyone, NBC News reported over the weekend.
One of the two drugs in Pfizer's Paxlovid antiviral cocktail could cause severe or life-threatening interactions with commonly used medications, including statins,
Newsmax (News)
Nov 05 2021
News
Covid: Pfizer says antiviral pill 89% effective in high risk cases
An experimental pill to treat Covid developed by the US company Pfizer cuts the risk of hospitalisation or death by 89% in vulnerable adults, clinical trial results suggest.
The drug - Paxlovid - is intended for use soon after symptoms develop in people at high risk of severe disease.
It comes a day after the UK medicines regulator approved a similar treatment from Merck Sharp
BBC News
Dec 22 2021
News
FDA authorizes Pfizer COVID antiviral pill for high-risk individuals
The Food and Drug Administration on Wednesday authorized Pfizer's antiviral pill for the treatment of individuals at high risk of severe illness from COVID-19.
Why it matters: At-home COVID-19 treatments, especially Pfizer's Paxlovid, are seen as possible game-changers for the pandemic. The emergency use authorization comes as the U.S. sees a surge in new COVID-19 cases and
Axios
Dec 22 2021
News
FDA authorizes first Covid pill, from Pfizer, for emergency use
The Food and Drug Administration on Wednesday authorized the first Covid-19 antiviral pill in the United States to protect against severe disease.
The oral drug, called Paxlovid, from Pfizer will be prescribed for use in adults and children ages 12 and up with mild to moderate Covid who are at risk for severe disease or hospitalization, the FDA said in a statement.
The
NBC News (Online)
Dec 22 2021
News
FDA authorizes first COVID-19 treatment pill, Pfizer's Paxlovin drug
The Food and Drug Administration authorized the first oral antiviral treatment for COVID-19, Pfizer's Paxlovid drug.
Emergency use authorization was granted Wednesday for Pfizer's Paxlovid – nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use – for the treatment of mild-to-moderate coronavirus disease in adults and children 12 years of age or older weighing at least 40
Fox Business
Apr 22 2022
News
WHO Warns Poor Nations Could Be Pushed to 'End of the Queue' for Pfizer Covid Pill
While strongly recommending the use of Paxlovid for high-risk Covid-19 patients who develop mild or moderate symptoms, the World Health Organization on Friday warned that without increasing testing access and the reach of generic production and consumption, the lifesaving medicine is likely to remain inaccessible in much of the Global South—replicating the injustice of vaccine apartheid.
Common Dreams
Nov 16 2021
News
8 lingering questions about the new Covid pills from Merck and Pfizer
The past two months have brought extremely good news in the fight against Covid-19. Two different oral treatments have proved effective at both preventing people newly diagnosed with Covid-19 from entering the hospital and from dying.
“We’re accelerating our path out of this pandemic,” President Biden said after data on the second Covid pill became available. The wide availability of
STAT
Oct 01 2021
News
Merck says experimental pill cuts worst effects of COVID-19
Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus, potentially a leap forward in the global fight against the pandemic.
The company said it will soon ask health officials in the U.S. and around the world to authorize the pill’s use. A decision from the U.S. Food and Drug
Associated Press
Nov 16 2021
News
Pfizer agrees to let other companies make its COVID-19 pill
Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental COVID-19 pill, a move that could make the treatment available to more than half of the world’s population.
In a statement issued Tuesday, Pfizer said it would grant a license for the antiviral pill to the Geneva-based Medicines Patent Pool, which would let generic drug
Associated Press
Nov 16 2021
News
Pfizer Will Allow Its Covid Pill to Be Made and Sold Cheaply in Poor Countries
Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.
The agreement follows a similar arrangement negotiated by Merck last month, and together the deals have the potential to vastly expand global production of two simple antiviral pills that could
New York Times (News)